Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia

American Journal of Clinical Pathology

Volumn 116, Issue 6, 2001, Pages 905-912

  Shen, P U F ^a   Fuller, S G ^a   Rezuke, W N ^a   Sherburne, B J ^a   DiGiuseppe, J A ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

CD38; Chronic lymphocytic leukemia; Flow cytometry; Immunoglobulin heavy chains; Immunophenotype

Indexed keywords

CD38 ANTIGEN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN M; ISOPROTEIN; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN;

ARTICLE; B CELL LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; HUMAN; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPHENOTYPING; LABORATORY DIAGNOSIS; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MEMORY CELL; MORPHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR CELL;

ADP-RIBOSYL CYCLASE; ANTIGENS, CD; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; B-LYMPHOCYTES; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN D; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN ISOTYPES; IMMUNOGLOBULIN M; IMMUNOPHENOTYPING; LEUKEMIA, B-CELL, CHRONIC; LEUKOCYTE COUNT; MEMBRANE GLYCOPROTEINS; NAD+ NUCLEOSIDASE; RECEPTORS, ANTIGEN, B-CELL;

EID: 0035179116     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/1TYF-VPM9-CQ2C-B0TF     Document Type: Article

References (39)

1. A revised EuropeanAmerican classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
2. The World Health Organization classification of hematological malignancies: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997
3. B-cell chronic lymphocytic leukemia: A bird of a different feather
4. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias
5. Trisomy 12 defines a group of CLL with atypical morphology: Correlation between cytogenetic, clinical and laboratory features in 544 patients
6. Further characterization of morphologically defined typical and atypical CLL: A clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases
7. Atypical lymphocyte morphology: An adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12
8. Karyotype correlates with peripheral blood morphology and immunophenotype in chronic lymphocytic leukemia
9. Trisomy 12 is seen within a specific subtype of B-cell chronic lymphoproliferative disease affecting the peripheral blood/bone marrow and cosegregates with elevated expression of CD11a
10. Genomic aberrations and survival in chronic lymphocytic leukemia
11. H genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities
12. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors
13. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia
14. H genes are associated with a more aggressive form of chronic lymphocytic leukemia
15. H genes is a detrimental prognostic factor in chronic lymphocytic leukemia
16. Prediction of VH gene mutation status in B-CLL using immunophenotyping and trephine histology
17. H gene mutation in B-cell chronic lymphocytic leukemia
18. Updated data on V gene mutation status and CD38 expression in B-CLL
19. Immunoglobulin V genes and CD38 expression in CLL
20. Prognostic implications of CD38 and myeloid-associated marker expression in B-CLL
21. CD38 expression defines clinical and biological characteristics in B-CLL
22. The mutational status of immunoglobulin V genes is the most important prognostic factor in B-CLL
23. Analysis of immunoglobulin VH genes in relation to CD38 expression in B cell chronic lymphocytic leukemia (B-CLL)
24. Lack of correlation between immunoglobulin somatic mutation and expression of CD38 in chronic lymphocytic leukemia
25. H gene mutational status and prognosis in chronic lymphocytic leukemia
26. Somatic hypermutation in normal and transformed human B cells
27. Mechanisms of disease: Cellular origin of human B-cell lymphomas
28. Analysis of somatic mutation in five B cell subsets of human tonsil
29. Variable region gene analysis of B cell subsets derived from a 4-year old child: Somatically mutated memory B cells accumulate in the peripheral blood already at young age
30. The imprint of somatic hypermutation on the repertoire of human germline V genes
31. Normal human IgD+IgM-germinal center B cells can express up to 80 mutations in the variable region of their IgD transcripts
32. The normal counterpart of IgD myeloma cells in germinal center displays extensively mutated IgVH gene, Cmu-Cdelta switch, and lambda light chain expression
33. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells
34. Histological and immunoglobulin VH gene analysis of interfollicular small lymphocytic lymphoma provides evidence for two types
35. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia
36. Clinical staging and immunological findings in chronic lymphocytic leukemia
37. Prognostic significance of immunoglobulin phenotype in B cell chronic lymphocytic leukemia
38. Surface immunoglobulin pattern of the leukaemic cell population in chronic lymphocytic leukemia (CLL) in relation to disease activity
39. H genes provides clinically valuable information in B-cell chronic lymphocytic leukemia